COMP <GO>
CSL vs FCX // REVENUE GROWTH (YOY)
Carlisle Companies Incorporated (NYSE) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: CSL 10
— FCX 5
▲ REVENUE GROWTH (YOY) LEADER: CSL
LAST: $376.31 (+1.33%) • MKT CAP: $14.75B
revenue-growth
0.30%
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
revenue-growth
0.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSL VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CSL | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | 26.10% | +9.60 | CSL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.20% | 21.50% | +0.70 | CSL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.8x | 13.4x | +1.40 | FCX | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 4.71% | +1.87 | CSL | /fcf-yield <GO> |
| Operating Margin | 20.00% | 25.90% | -5.90 | FCX | /operating-margins <GO> |
| Net Profit Margin | 14.80% | 8.80% | +6.00 | CSL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 0.30% | 0.10% | +0.20 | CSL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.23% | 0.91% | +0.32 | CSL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.21 | 3.08 | +3.13 | CSL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | FCX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.5 | 30.2 | +41.31 | CSL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.95 | +0.13 | CSL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.5x | 40.1x | -21.60 | CSL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.75B | $94.98B | -$80.23B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CSL REV | FCX REV | CSL GROSS % | FCX GROSS % | CSL FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.02B | $25.19B | 35.7% | 26.1% | $970.6M | $4.48B |
| FY 2024 | $5.00B | $25.17B | 37.7% | 29.3% | $917.0M | $6.03B |
| FY 2023 | $4.59B | $22.70B | 44.0% | 44.0% | $994.9M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSL // BETA 1.08
FCX // BETA 0.95